The aim of the present study is to evaluate the impact of Covid-19 on utilization of chronic diseases services.
Methods
Interrupted time-series design was used to examine the utilization of chronic diseases services before and during the Covid-19 pandemic among hospitals in Iran. Chronic obstructive pulmonary disease (COPD), asthma, type 2 diabetes, heart failure, and chemotherapy were selected as a proxy to indicate the impact of Covid-19 on utilization of chronic diseases services. Data were collected in 24 sites from 12 months before the onset of Covid-19 (from March 2019 to February 2020) to 12 months during the Covid-19 pandemic (February 2020 to March 2021).
Results
A total of 7,039,378 services were provided, of which 51.92% were provided for women and 62.73% for >65 age group. A sudden decrease was observed in monthly utilization of services during the Covid-19 pandemic; ranging from 13.91 (95% CI = −21.73, 6.10, P = 0.001) for chemotherapy to 606.39 (95% CI = −1040.72, 172.06, P = 0.009) for heart failure services per 100 thousand population. A decrease was observed in COPD services; 15.28 services compared with the period before Covid-19. Subsequently, the monthly utilization trends of asthma, type 2 diabetes, and chemotherapy services increased significantly (P < 0.05).
Discussion
Although chronic diseases are a factor in more severe form of Covid-19, their failure to seek diagnostic, prevention and treatment services has somewhat complicated the issue.
GhaderiEMahmoodiHSharifi SaqqeziP, et al.Knowledge, attitudes, practices and fear of COVID-19 among Iranians: a quick online survey. Health & social care in the community. Health Soc Care Community2020; 30: 1154–1162.
2.
NishijimaCMiyagawaNTsuboyama-KasaokaN, et al.Association between lifestyle changes and at-home hours during and after the state of emergency due to the COVID-19 pandemic in Japan. Nutrients2021; 13: 2698.
3.
MoradiGMohamadi BolbanabadAAhmadiS, et al.Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020. Int Immunopharmacol2021; 98: 107893.
4.
BlanchetKAlwanAAntoineC, et al.Protecting essential health services in low-income and middle-income countries and humanitarian settings while responding to the COVID-19 pandemic. BMJ Glob Health2020; 5: e003675.
5.
SchneiderCH. Health system governance and the UHC agenda: key learnings from the COVID-19 pandemic. BMJ Glob Health2021; 6: e006519.
6.
RomanelliRJAzarKMSudatS, et al.Learning health system in crisis: lessons from the COVID-19 pandemic. Mayo Clin Proc Innov Qual Outcomes2021; 5: 171–176.
7.
ZhangPGaoJ. Evaluation of China's public health system response to COVID-19. J Glob Health2021; 11: 05004.
8.
EaneffSObermeyerZButteAJ. Algorithmic stewardship in health care—reply. JAMA2021; 325: 588–589.
9.
MärzJWHolmSSchlanderM. Resource allocation in the COVID-19 health crisis: are COVID-19 preventive measures consistent with the rule of rescue?Med Health Care Philos2021; 24: 487–492.
10.
EhmannMRZinkEKLevinAB, et al.Operational recommendations for scarce resource allocation in a public health crisis. Chest2021; 159: 1076–1083.
11.
NemesMIBHelenaETSCaracioloJM, et al.Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches. Cadernos de Saúde Pública2009; 25: S392–S400.
12.
LimSSVosTFlaxmanAD, et al.A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2020; 380: 2224–2260.
13.
MoussaviSChatterjiSVerdesE, et al.Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet2007; 370: 851–858.
14.
SinghKKaushikAJohnsonL, et al.Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study. BMJ open2021; 11: e048926.
15.
HigginsVSohaeiDDiamandisEP, et al.COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab2021; 58: 297–310.
16.
BernalJLCumminsSGasparriniA. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol2017; 46: 348–355.
17.
DennisJRamsayTTurgeonAF, et al.Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis. Br Med J2013; 346: f2674.
18.
LauWCMurrayMEl-TurkiA, et al.Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom. Vaccine2015; 33: 5072–5079.
19.
RamsayCRMatoweLGrilliR, et al.Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care2003; 19: 613–623.
20.
RiaziHJafarpourMBitarafE. Towards national eHealth implementation—a comparative study on WHO/ITU national eHealth strategy toolkit in Iran. Stud Health Technol Inform2014; 205: 246–250.
21.
WagnerAKSoumeraiSBZhangF, et al.Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther2002; 27: 299–309.
22.
RashidianAJoudakiHKhodayari-MoezE, et al.The impact of rural health system reform on hospitalization rates in the Islamic Republic of Iran: an interrupted time series. Bull World Health Organ2013; 91: 942–949.
23.
ChudasamaYVGilliesCLZaccardiF, et al.Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr2020; 14: 965–967.
24.
DanhieuxKBuffelVPaironA, et al.The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium. BMC Fam Pract2020; 21: 255.
25.
KalanjKMarshallRKarolK, et al.The impact of COVID-19 on hospital admissions in Croatia. Front Public Health2021; 9: 720948.
26.
FordeRArenteLAusiliD, et al.The impact of the COVID-19 pandemic on people with diabetes and diabetes services: a pan-European survey of diabetes specialist nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium. Diabet Med2021; 38: e14498.
27.
CarrMJWrightAKLeelarathnaL, et al.Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol2021; 9: 413–415.
28.
SankaranarayananRHartshorne-EvansNRedmond-LyonS, et al.The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study. ESC Heart Fail2021; 8: 1324–1332.
29.
CharmanSJVelickiLOkwoseNC, et al.Insights into heart failure hospitalizations, management, and services during and beyond COVID-19. ESC Heart Fail2021; 8: 175–182.
30.
RieraRBagattiniÂMPachecoRL, et al.Delays and disruptions in cancer health care due to COVID-19 pandemic. Systematic review. JCO Glob Oncol2021; 7: 311–323.
31.
KyriakopoulosCGogaliAExarchosK, et al.Reduction in hospitalizations for respiratory diseases during the first COVID-19 wave in Greece. Respiration2021; 100: 588–593.
32.
TangMDanielsBAslamM, et al.Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study. Lancet Reg Health West Pac2021; 14: 100226.
33.
SykesDLFaruqiSHoldsworthL, et al.Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective. RJ Open Res2021; 7: 00822–02020.
34.
RimmerA. Respiratory workforce is in a state of constant crisis, doctors warn. Br Med J2021; 372: n497.
35.
MohseniMAhmadiSAzami-AghdashS, et al.Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes2021; 15: 918–922.
36.
EmamiAJavanmardiFPirbonyehN, et al.Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of Academic Emergency Medicine2020; 8: 8.
37.
AlyammahiSKAbdinSMAlhamadDW, et al.The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol2021; 87: 104647.
38.
BelkacemANOuhbiSLakasA, et al.End-to-end AI-based point-of-care diagnosis system for classifying respiratory illnesses and early detection of COVID-19: a theoretical framework. Front Med (Lausanne)2021; 8: 72.
